Insmed Incorporated Revenue and Competitors
Estimated Revenue & Valuation
- Insmed Incorporated's estimated annual revenue is currently $173.8M per year.
- Insmed Incorporated received $437.3M in venture funding in January 2018.
- Insmed Incorporated's estimated revenue per employee is $217,459
- Insmed Incorporated's current valuation is $2.8B. (January 2022)
- Insmed Incorporated has 799 Employees.
- Insmed Incorporated grew their employee count by 13% last year.
Insmed Incorporated Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Insmed Incorporated?
Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market therapies that make a real difference in patients lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. Headquartered in Bridgewater, NJ, we are a rapidly growing company with offices in seven countries.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
Insmed Incorporated News
Goldman Sachs Group Inc. now owns 463,326 shares of the biopharmaceutical company's stock valued at $12,621,000 after purchasing an additional...
Brokerages expect Insmed Incorporated (NASDAQ:INSM Get Rating) to announce sales of $53.63 million for the current quarter,...
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases.
BRIDGEWATER, N.J., Oct. 28, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the third quarter ended September 30, 2021 and provided a bu ...
BRIDGEWATER, N.J., May 19, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported data from a total of nine posters and oral presentations across its three program ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Insmed Incorporated Funding
|2003-07-14||$12.0M||Private Placement||Wells Fargo Securities||Article|
|2007-05-07||$18.2M||Undisclosed||CE Unterberg Towbin||Article|
|2013-07-18||$62.4M||Undisclosed||Leerink Swann LLC||Article|
|2017-09-08||$402.5M||Undisclosed||Goldman Sachs & Co. LLC||Article|
|2018-01-24||$300.0M||Undisclosed||Goldman Sachs & Co. LLC||Article|
|2018-01-25||$437.3M||Undisclosed||Goldman Sachs & Co. LLC||Article|